FDA Alerts Consumers of BioLyte Laboratories Voluntary Recall of NeoRelief
Audience: Consumer
[9/14/2018] The Food and Drug Administration is alerting consumers and health care professionals about a voluntary recall of certain lots (1138, 1139, 1146, and 1160) of NeoRelief distributed by BioLyte Laboratories (Grand Rapids, Michigan). NeoRelief is labeled as a homeopathic topical for the temporary relief of occasional muscle cramps, restlessness and twitching and is being recalled due to microbial contamination at the active ingredient manufacturing facility.
Administration or use of drug products with microbial contamination could potentially result in increased infections that may require medical intervention.
Some of NeoReief’s active ingredients were manufactured at a King Bio Inc. facility in Asheville, North Carolina. Previously, FDA alerted consumers of HelloLife’s voluntary recall of drug products labeled as homeopathic and Beaumont Bio Med’s voluntary recall of all water- and alcohol-based products, which are also manufactured by King Bio.
Health care professionals and patients are encouraged to report any adverse events associated with Beaumont’s drug products to the FDA’s MedWatch Adverse Event Reporting.
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.